Anti-DIABLO monoclonal antibody

Pre-made anti-DIABLO monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DIABLO/DIABLO products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0216-Ab-1/ GM-Tg-hg-IP0216-Ab-2Anti-Human DIABLO monoclonal antibodyHuman
GM-Tg-rg-IP0216-Ab-1/ GM-Tg-rg-IP0216-Ab-2Anti-Rat DIABLO monoclonal antibodyRat
GM-Tg-mg-IP0216-Ab-1/ GM-Tg-mg-IP0216-Ab-2Anti-Mouse DIABLO monoclonal antibodyMouse
GM-Tg-cynog-IP0216-Ab-1/ GM-Tg-cynog-IP0216-Ab-2Anti-Cynomolgus/ Rhesus macaque DIABLO monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0216-Ab-1/ GM-Tg-felg-IP0216-Ab-2Anti-Feline DIABLO monoclonal antibodyFeline
GM-Tg-cang-IP0216-Ab-1/ GM-Tg-cang-IP0216-Ab-2Anti-Canine DIABLO monoclonal antibodyCanine
GM-Tg-bovg-IP0216-Ab-1/ GM-Tg-bovg-IP0216-Ab-2Anti-Bovine DIABLO monoclonal antibodyBovine
GM-Tg-equg-IP0216-Ab-1/ GM-Tg-equg-IP0216-Ab-2Anti-Equine DIABLO monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0216-Ab-1/ GM-Tg-hg-IP0216-Ab-2; GM-Tg-rg-IP0216-Ab-1/ GM-Tg-rg-IP0216-Ab-2;
GM-Tg-mg-IP0216-Ab-1/ GM-Tg-mg-IP0216-Ab-2; GM-Tg-cynog-IP0216-Ab-1/ GM-Tg-cynog-IP0216-Ab-2;
GM-Tg-felg-IP0216-Ab-1/ GM-Tg-felg-IP0216-Ab-2; GM-Tg-cang-IP0216-Ab-1/ GM-Tg-cang-IP0216-Ab-2;
GM-Tg-bovg-IP0216-Ab-1/ GM-Tg-bovg-IP0216-Ab-2; GM-Tg-equg-IP0216-Ab-1/ GM-Tg-equg-IP0216-Ab-2
Products NameAnti-DIABLO monoclonal antibody
Formatmab
Target NameDIABLO
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DIABLO monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0216-Ag-1Recombinant multi-species DBLOH/ DIABLO/ DFNA64 protein
    ORF Viral VectorvGMLV000088human DIABLO Lentivirus particle
    ORF Viral VectorpGMLV000088human DIABLO Lentivirus plasmid
    ORF Viral VectorpGMLPm000817mouse Diablo Lentivirus plasmid
    ORF Viral VectorvGMLPm000817mouse Diablo Lentivirus particle


    Target information

    Target IDGM-IP0216
    Target NameDIABLO
    Gene ID56616,66593,288753,701896,477463,768282,493999,100058709
    Gene Symbol and Synonyms0610041G12Rik,1700006L01Rik,DBO,DFNA64,DIABLO,SMAC
    Uniprot AccessionQ9NR28
    Uniprot Entry NameDBLOH_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000184047
    Target ClassificationTumor-associated antigen (TAA)

    The target: DIABLO, gene name: DIABLO, also named as DFNA64, SMAC. This gene encodes an inhibitor of apoptosis protein (IAP)-binding protein. The encoded mitochondrial protein enters the cytosol when cells undergo apoptosis, and allows activation of caspases by binding to inhibitor of apoptosis proteins. Overexpression of the encoded protein sensitizes tumor cells to apoptosis. A mutation in this gene is associated with young-adult onset of nonsyndromic deafness-64. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.